ARCHIVES

Spring Meetings Will Concentrate Everyone In New Orleans – Except The Nurses

This article is from The Cancer Letter archive.

Vol. 14 No. 13 | March 25, 1988

Download PDF Visit The Full Archive

Related Articles

Tumor Treating Fields Therapy Increased Three-Year Survival

November 25, 2011

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012

In Brief: Schepartz To Leave NCI for Academia; Woolley Names To Head Clinical Research At Lombardi

March 9, 1984

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

May 8, 2013

Omnibus bill recissions would cut $28 million from NCI FY04 budget.

January 9, 2004

Study: Prostate Cancer Classifier Can Predict Risk Better Than PSA, Gleason Score, Tumor Stage

February 28, 2014